- Home
- CPRX vs AI Comparison
CPRX vs AI Comparison
Compare CPRX & AI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CPRX
- AI
- Stock Information
- Founded
- CPRX 2002
- AI 2009
- Country
- CPRX United States
- AI United States
- Employees
- CPRX N/A
- AI N/A
- Industry
- CPRX Biotechnology: Pharmaceutical Preparations
- AI Computer Software: Prepackaged Software
- Sector
- CPRX Health Care
- AI Technology
- Exchange
- CPRX Nasdaq
- AI Nasdaq
- Market Cap
- CPRX 2.6B
- AI 2.4B
- IPO Year
- CPRX 2006
- AI 2020
- Fundamental
- Price
- CPRX $21.29
- AI $17.99
- Analyst Decision
- CPRX Strong Buy
- AI Hold
- Analyst Count
- CPRX 5
- AI 15
- Target Price
- CPRX $33.20
- AI $24.62
- AVG Volume (30 Days)
- CPRX 1.4M
- AI 7.6M
- Earning Date
- CPRX 11-05-2025
- AI 12-08-2025
- Dividend Yield
- CPRX N/A
- AI N/A
- EPS Growth
- CPRX 183.96
- AI N/A
- EPS
- CPRX 1.65
- AI N/A
- Revenue
- CPRX $558,499,000.00
- AI $372,104,000.00
- Revenue This Year
- CPRX $16.59
- AI N/A
- Revenue Next Year
- CPRX $8.80
- AI $11.61
- P/E Ratio
- CPRX $12.72
- AI N/A
- Revenue Growth
- CPRX 28.55
- AI 14.34
- 52 Week Low
- CPRX $19.05
- AI $14.70
- 52 Week High
- CPRX $26.58
- AI $45.08
- Technical
- Relative Strength Index (RSI)
- CPRX 57.67
- AI 47.52
- Support Level
- CPRX $20.66
- AI $17.20
- Resistance Level
- CPRX $21.55
- AI $18.39
- Average True Range (ATR)
- CPRX 0.57
- AI 0.86
- MACD
- CPRX 0.05
- AI -0.07
- Stochastic Oscillator
- CPRX 84.24
- AI 30.63
About CPRX Catalyst Pharmaceuticals Inc.
Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing, developing therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers three drug products, FIRDAPSE (amifampridine), FYCOMPA (perampanel), and AGAMREE (vamorolone).
About AI C3.ai Inc.
C3.ai Inc is an enterprise artificial intelligence company. The company provides software-as-a-service applications that enable customers to rapidly develop, deploy, and operate large-scale Enterprise AI applications across any infrastructure. It provides solutions under three divisions namely, The C3 AI Platform, which is an end-to-end application development and runtime environment for designing, developing, and deploying AI applications: C3 AI Applications, which is a portfolio of pre-built, extensible, industry-specific, and application-specific Enterprise AI applications: and C3 Generative AI, which combines the utility of large language models. Geographically the company derives revenue from North America, Europe, the Middle East and Africa, Asia Pacific, and the Rest of the World.